We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website. We have recently upgraded our technology platform. Due to this change if you are seeing this message for the first time please make sure you reset your password using the Forgot your password Link. Pharmaceuticals Regulation. AstraZeneca said its Symbicort Turbuhaler is the first approved dual-combination therapy for mild, moderate and severe asthma in China.
Credit: kalhh from Pixabay. The British drugmaker said that its Symbicort Turbuhaler is the first dual-combination therapy approved as an anti-inflammatory reliever in China for the treatment of mild asthma.
We are building on a year heritage in respiratory disease, and our capability in inhalation technology spans both pressurised metered-dose inhalers pMDIs and dry powder inhalers DPIs , as well as our innovative Co-Suspension TM Delivery Technology. Our research is focused on four key biological pathways: eosinophilic disease, Th2-driven disease, epithelial-driven pathobiology and autoimmunity.
The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over countries and its innovative medicines are used by millions of patients worldwide.
For more information, please visit www. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. AstraZeneca provides this link as a service to website visitors.
AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit. Important notice for users You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data.
Please refer to your approved national product label SmPC for current product information. I have read this warning and will not be using any of the contained product information for clinical purposes. Search Menu. Search Search Search Close. References Symbicort Prescribing Information. Last accessed January Lanz, Miguel et al.
0コメント